Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2007

View Archived Issues

Recent patents cover new therapeutic agents for cancer

Novel treatments for musculoskeletal and connective tissue disorders claimed in recent patents

Recent Schering and Epix patents disclose novel MRI agents

Novel treatment options for gastrointestinal disorders reported in recent patents

Phase IIa study of oleoyl-estrone for obesity completes enrollment

Identification of active sites of Polo-like kinases useful for developing new cancer therapies

Access to acquire Somanta

GCN2 critical for regulating fat metabolism during essential amino acid deprivation

Apollo Life Sciences reduces inflammation with oral TNF blocker

Dyax and Genzyme end DX-88 joint venture

IAVI applauds creation of Canadian HIV Vaccine Initiative

Avax collaborates with CTCA on O-Vax vaccine

AlphaRx's nanoparticle drug delivery system shows potential in tuberculosis

GPC Biotech launches satraplatin expanded access program

TransTech licenses Novo Nordisk's GKA program

Hybrigenics focuses research on USP inhibitors for cancer

DiaKine licenses cytokine modulators from U. of Virginia

Orphan drug status awarded to rhPDGF-BB for osteonecrosis of the jaw

Pharmacyclics receives refusal to file letter for Xcytrin

Avastin plus chemotherapy improves PFS in advanced NSCLC patients

Indena patents novel compounds for treating skeletal muscle spasms

Fosrenol launched in U.K.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...